354033 <common-name>3-[[4-[[4,4-diphenyl-2,5-bis(sulfanylidene)imidazolidin-1-yl]methyl]piperazin-1-yl]methyl]-5,5-diphenylimidazolidine-2,4-dithione</common-name> <description>3-[[4-[[4,4-diphenyl-2,5-bis(sulfanylidene)imidazolidin-1-yl]methyl]piperazin-1-yl]methyl]-5,5-diphenylimidazolidine-2,4-dithione is a chemical compound with the formula C36H34N6S4. With an average molecular weight of 679.00 g/mol, 3-[[4-[[4,4-diphenyl-2,5-bis(sulfanylidene)imidazolidin-1-yl]methyl]piperazin-1-yl]methyl]-5,5-diphenylimidazolidine-2,4-dithione is a heavy molecule.</description> <cas>21616-41-1</cas> <pubchem-id>3038243</pubchem-id> <chemical-formula>C36H34N6S4</chemical-formula> <weight>679</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T21:18:45Z</created-at> <updated-at type="dateTime">2026-08-31T21:18:45Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1CN(CCN1CN2C(=S)C(NC2=S)(C3=CC=CC=C3)C4=CC=CC=C4)CN5C(=S)C(NC5=S)(C6=CC=CC=C6)C7=CC=CC=C7</moldb-smiles> <moldb-formula>C36H34N6S4</moldb-formula> <moldb-inchi>InChI=1S/C36H34N6S4/c43-31-35(27-13-5-1-6-14-27,28-15-7-2-8-16-28)37-33(45)41(31)25-39-21-23-40(24-22-39)26-42-32(44)36(38-34(42)46,29-17-9-3-10-18-29)30-19-11-4-12-20-30/h1-20H,21-26H2,(H,37,45)(H,38,46)</moldb-inchi> <moldb-inchikey>AKTNXIRDLGSALP-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">678.1727798</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.8</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM349926</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>3-[[4-[[4,4-diphenyl-2,5-bis(sulfanylidene)imidazolidin-1-yl]methyl]piperazin-1-yl]methyl]-5,5-diphenylimidazolidine-2,4-dithione</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass>Diphenylmethanes</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0304315</sync-id> <structure-inchikey>AKTNXIRDLGSALP-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>20800040000000000000008000000000000000008000100000000000000000000000000000000004020000000000000000000000000000000000000008000000080000000000000000000000000000000000000000000028000000000000000400000000000800000000020100000000000000000000000000000008000000800000200000000000000000000100000000000000008000000000000000000000000000080000000000000000000000008000000000000000000040000000000000000000000000001000000000040000000200000000010010000000000000000040000000000000010000000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAuAAAANAAAAIABBgBgAAAAAgIGAGAAAAAC AgcAIAAAAAMGAGAAAAACAgYAYAAAAAICBwAgAAAAAwYAYAAAAAICBwAoAAAA AwMGACgAAAADBBAAKAAAAAMCBgAgAAAABAcAaAAAAAMCAQYAKAAAAAMEEAAo AAAAAwIGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAA AAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAA AwMBBkBoAAAAAwMBBkBoAAAAAwMBBgBgAAAAAgIHACgAAAADAwYAKAAAAAME EAAoAAAAAwIGACAAAAAEBwBoAAAAAwIBBgAoAAAAAwQQACgAAAADAgZAKAAA AAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAA AwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAAD AwEGQGgAAAADAwELAAEAAQIAAgMAAwQABAUABQYABgcABwggCAkoAggKAAoL AAsMIAwNKAIKDgAOD2gMDxBoDBARaAwREmgMEhNoDAoUABQVaAwVFmgMFhdo DBcYaAwYGWgMAhoAGhsAGxwgHB0oAhweAB4fAB8gICAhKAIeIgAiI2gMIyRo DCQlaAwlJmgMJidoDB4oACgpaAwpKmgMKitoDCssaAwsLWgMBQAADAcgEw5o DBkUaAwgGyAnImgMLShoDEIHAAAABgAFBAMCAQUIBwwLCgYPEBESEw4GFRYX GBkUBRwbIB8eBiMkJSYnIgYpKissLSgXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:51:51Z</structure-indexed-at> </compound>